
Johnson & Johnson (JNJ) received a 77% rating from Validea's guru fundamental report, utilizing Partha Mohanram's P/B Growth Investor model, which targets low book-to-market stocks with sustained growth characteristics. Although JNJ passed most of the model's financial criteria, it notably failed on "Advertising to Assets" and "Research and Development to Assets," resulting in a score just below the 80% threshold typically indicating "some interest" for the strategy.
Johnson & Johnson (JNJ) scores a moderately positive 77% based on Validea's implementation of Partha Mohanram's P/B Growth Investor model, placing it just below the 80% threshold that typically signifies strategic interest. The analysis indicates JNJ is a large-cap growth stock that successfully passes key fundamental tests for a low book-to-market company, including Return on Assets (ROA), Cash Flow from Operations to Assets, and stability metrics like ROA and Sales Variance. However, the model registers critical failures on two forward-looking indicators: Advertising to Assets and Research and Development to Assets. While JNJ exhibits characteristics of a financially healthy and stable company, its lower investment in these specific growth-driving activities, as measured by the model's criteria, prevents it from being classified as a high-conviction pick under this particular growth-focused academic framework.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment